Bladder & Urethral Disorders Flashcards
2nd MC urologic cancer
MC in who?
Bladder Cancer
men (~3:1) and older pts (avg age at dx - 73)
risk factors for bladder cancer
- Cigarettes - 60% of new cases
- Industrial solvents - 15% of new cases
- Chronic inflammation - UTIs, catheters, bladder stones
Epidemiology of bladder cancer
98% - epithelial cell malignancies
- 90% - urothelial cell carcinoma
- 7% - squamous cell carcinoma - chronic inflammation
- Bladder stones
- Prolonged catheter use
- Chronic UTIs
- Schistosomiasis - 2% - adenocarcinomas
s/s of bladder cancer
-
Hematuria (85-90%)
- Micro or gross, intermittent or chronic
- Often painless - +/- irritative voiding (depending on size, location)
- Many pts - no major s/s in early stages! - Weight loss possible
- Large - may see abdominal mass
- Metastatic - hepatomegaly, LAN +/- lymphedema
lab findings of bladder cancer
- Hematuria (gross/micro)
- +/- pyuria, anemia - If obstruction - signs of AKI
- Urine cytology - abnormal shed epithelial cells
- 80-90% sensitive in higher grade/stage
- 50% sensitive in noninvasive or well-differentiated - Urine biomarkers - new; not preferred over cystoscopy
imaging and diagnostic for bladder cancer
- Imaging
- CT, MRI or US may show mass within bladder
- “Filling defect” -
Cystoscopy w/ bx - gold standard
- Local anesthesia - can ID mass within the bladder
- Can perform local resection (regional or total anesthesia)
tx for bladder cancer
- Superficial (TIS, Ta, T1) - transurethral tumor resection
- +/- intravesical chemotherapy
- Weekly x 6-12 wks - BCG is often most effective form
— May require anti-TB treatment
— Alternative agents available - Invasive (T2 +) - radical cystectomy, urinary diversion
- +/- chemotherapy, immunotherapy, radiation
prognosis for bladder cancer
- Superficial ,5-year survival - 81%
- 50-80% are superficial - Invasive, 5-year survival - 50-75%
- Metastatic (T4) - long-term survival is rare
repeated urination into clothing or bedding
what is this term?
enuresis
Some sources - only applies if child is 5+ years old
May be associated with neurodevelopmental problems
no other LUTS and no history of bladder disorders
what is this term? (for Nocturnal Enuresis)
Monosymptomatic enuresis
urination occurring specifically during bedtime/sleeping hours
what term is this
nocturnal enuresis
2 types of nocturnal enuresis
- Primary - usually in young children < 5-6 years old; have never achieved urinary continence
- Secondary - patients who previously were fully continent for 6+ months
- Often associated with a stressful
who MC has nocturnal enuresis
males
About 15% of pts/yr have spontaneous resolution
5 years: 16%
6 years: 13%
7 years: 10%
8 years: 7%
10 years: 5%
12-14 years: 2-3%
≥15 years: 1-2%
↑ duration = ↓ likelihood of
spontaneous resolution
Tx for nocturnal enuresis before age ___ is usually not recommended!
5
Involuntary urination during sleep in a person who normally has voluntary urinary control
Usually occurs 3-4 hours after bedtime
Confusion and amnesia possible
this presentation is for what dx?
nocturnal enuresis
- Investigate for other conditions
- Polydipsia - DM, DI, primary polydipsia
- Infections - UTI, pinworms
- Other causes - CKD, bladder disease, constipation, seizures
what can delineate timing, frequency and severity for nocturnal enuresis
voiding diaries
diagnostics for nocturnal enuresis
as needed to rule out other causes
- Infections, emotional distress, diabetes, epilepsy, etc.
- UA - generally indicated for most pts
- US - can help look for anatomic abnormalities
tx for nocturnal enuresis
- Lifestyle Changes
- Voiding - frequently in day (4-7x) and just before bed
- Fluids - avoid excess fluids in the evening
— Especially sugary/caffeinated
- Pull-Ups - discourage use in older children
- Education - bedwetting is unintentional
— Primary usually resolves by puberty - Interventions
- tx of coexisting conditions
- Similar outcomes for behavioral vs meds
- Behavioral - enuresis alarm
— 3-4 months
— Lower relapse rates, but require a
highly motivated family
- meds - desmopressin (1st line)
— Good for short-term improvement
— 2nd line - imipramine, oxybutinin (add-on)
etiology of interstitial cystitis
Unknown
- Possible allergic response, inflammatory/autoimmune, abnormal epithelium, abnormal sensorineural response
- possibly several diseases with similar sx
Epidemiology of Interstitial Cystitis
- MC women (5:1)
- 18-40 per 100,000 patients
- MC diagnosed in 40s or later
risk factors for interstitial cystitis
- Associated w/ chronic pain syndromes (IBS, fibromyalgia)
- Certain foods/drinks may trigger
- alc, caffeine, citrus, spicy
presentation + labs for interstitial cystitis
- pain/discomfort with bladder filling, classically is relieved w/ urination
- pain range from mild-debilitating
- +/- irritative voiding sx
— nocturia, frequency, urgency
- Suprapubic tenderness often seen on exam - labs - normal
- UA
- Urine C&S
- Urine cytology
- Urodynamics
imaging for Interstitial Cystitis
- US - Postvoid residual (PVR) to rule out urinary retention
- Cystoscopy - helps rule out bladder CA
- May have findings associated with IC
how does the AUA diagnose interstitial cystitis
- Unpleasant sensation (pain, pressure, discomfort) perceived as relating to urinary bladder, with other LUTS, for >6 wks duration, in absence of infection or other identifiable causes
- No solid confirmatory PE finding, lab test or imaging!
— Used to r/o other dx
what interventions can be used for interstitial cystitis
- Cystoscopy - Not required to make dx
- Can help r/o other etiologies - Hydrodistension - improves s/s in 20-30%
Cystoscopy findings associated with IC:
- Hunner’s ulcers/lesions (only in
5-10% of pts) - Glomerulations (nonspecific - also seen
in 45% of healthy pts) - Increased mast cells on bx
Interstitial Cystitis - Treatment
Goal - No cure - symptomatic relief
- sx may spontaneously improve
- Pt education and psychosocial support significantly help
- First Line - Lifestyle modifications/Self care
- Second Line - Oral meds
- TCAs - amitriptyline - 1st line rx
- Antihistamines - hydroxyzine
- CCBs - nifedipine
- Pentosan polysulfate sodium (PPS) - Invasive therapies
- Hydrodistension
- Electrocauterization of Hunner lesions (if present)
- Intravesical lidocaine, heparin, or dimethyl sulfoxide (DMSO)
Only drug FDA-approved for tx of IC
pentosan polysulfate sodium (PPS); Elmiron
MOA of pentosan polysulfate sodium (PPS); Elmiron
May improve glycosaminoglycan layer over urothelium
SE of pentosan polysulfate sodium (PPS); Elmiron
- GI upset, elevated LFTs, hair loss
- Less sedation than TCAs, antihistamines
- Longer to see results than other meds for IC
- Case reports of retinal toxicity/macular disease - dose-related
CI with pentosan polysulfate sodium (PPS); Elmiron
allergy to drug or to heparin or LMWH
DDI with pentosan polysulfate sodium (PPS); Elmiron
anticoagulants/antiplatelets (↑ bleeding)
what tx for Interstitial Cystitis is for refractory cases (more SE and/or ? efficacy)
Botulinum injections to detrusor muscle
Sacral neuromodulation
Cystectomy with urinary diversion (last resort)